Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
India's Nicholas Piramal India Ltd. has bolstered its drug discovery efforts through two technology-licensing pacts with the U.K.-based research firm Morvus Technology. Under the first agreement, NPIL will use Morvus' gene and protein identification technology to find new drugs to treat diabetes and arthritis. The second pact covers a combination therapy for cancer that uses a cyclin-dependent kinase inhibitor to amplify the effectiveness of anticancer drugs. Morvus will receive up-front and milestone payments, as well as a 2% royalty on products that reach the market.
This article has been sent to the following recipient: